ArticleExploratory research in clinical and social pharmacy2026
Field survey on warnings to prevent drug abuse when selling over-the-counter drugs at drugstores.
Article in Exploratory research in clinical and social pharmacy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The abuse of over-the-counter (OTC) medications is increasing and has led to a rise in overdose cases. This study examined commonly misused OTC drugs, developed checklist items related to warnings provided during their sale, and conducted field surveys to compare practices based on whether products contained ingredients designated by the Ministry of Health, Labour and Welfare (MHLW), Japan. Methods: An eight items checklist was developed using MHLW-specified survey items, with additional items added by the researchers. Using this checklist, a researcher evaluated OTC purchases for 25 different drugs by marking each item as positive () or negative (×) from 17 drugstores. Results: Across 25 products surveyed, the most common positive item was "explanation by a qualified person" (11 positives, 44 %), followed by "point-of-purchase (POP) warning displays" (9 positives, 36 %) and "display near the cash register" (8 positives, 32 %). For OTC drugs containing designated ingredients ( Conclusion: To intervene with targets to prevent abuse and issue warnings about OTC drugs during a sale, proactive warnings about misused OTC drugs that do not contain designated ingredients are necessary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.